InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,307.88
(
0.48%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.69
(
0.32%
)
Bitcoin
61,564.88
(
-0.07%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Stately

Send PM Follow Ignore
Followers 9
Posts 733
Boards Moderated 0
Alias Born 06/26/2009

Stately

Re: montanus post# 19675

Friday, 03/11/2016 10:50:57 AM

Friday, March 11, 2016 10:50:57 AM

Post# of 20775
I'm not understanding what you're saying here...the company's last PR was about a scientific paper that was correlated to their license programs. How is this different? Are you agreeing or disagreeing that this means Pfizer wants to move forward with ponezumab for CAA?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up